Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,052
archived clinical trials in
Nephrology

A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
University of Minnesota - Division of Pediatric Nephrology
552
mi
from
Minneapolis, MN
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Minnesota - Division of Pediatric Nephrology
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
414
mi
from
Saint Louis, MO
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
414
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Nephrology Associates, PC
1296
mi
from
Flushing, NY
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Nephrology Associates, PC
1296
mi
from
Flushing, NY
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
726
mi
from
Cincinnati, OH
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
898
mi
from
Cleveland, OH
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
South Carolina Nephrology & Hypertension Center
995
mi
from
Orangeburg, SC
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
South Carolina Nephrology & Hypertension Center
995
mi
from
Orangeburg, SC
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Renal Disease Research Institute
344
mi
from
Dallas, TX
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Renal Disease Research Institute
344
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Southwest Houston Research, Ltd
569
mi
from
Houston, TX
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Southwest Houston Research, Ltd
569
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Advancement Center, PLLC
575
mi
from
San Antonio, TX
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Advancement Center, PLLC
575
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
South Florida Research Institute
1305
mi
from
Lauderdale Lakes, FL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
South Florida Research Institute
1305
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Scripps Clinic, Nephrology
1142
mi
from
La Jolla, CA
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Scripps Clinic, Nephrology
1142
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
David Geffen School of Medicine, UCLA
1177
mi
from
Los Angeles, CA
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
David Geffen School of Medicine, UCLA
1177
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Boise Kidney & Hypertension Institute, PLLC
1066
mi
from
Caldwell, ID
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Boise Kidney & Hypertension Institute, PLLC
1066
mi
from
Caldwell, ID
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Biolab Research, LLC
1120
mi
from
Rockville, MD
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Biolab Research, LLC
1120
mi
from
Rockville, MD
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
University of Michigan
808
mi
from
Ann Arbor, MI
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Michigan
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Columbia University Nephrology
1290
mi
from
New York, NY
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Columbia University Nephrology
1290
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
University of Utah Health
777
mi
from
Salt Lake City, UT
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Utah Health
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
The Children's Hospital of Philadelphia (CHOP)
1225
mi
from
Philadelphia, PA
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
The Children's Hospital of Philadelphia (CHOP)
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Arizona Kidney Disease and Hypertension Research Services, PLLC
843
mi
from
Phoenix, AZ
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Arizona Kidney Disease and Hypertension Research Services, PLLC
843
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
General Clinical Research Center - Parnassus
1341
mi
from
San Francisco, CA
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
General Clinical Research Center - Parnassus
1341
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
University of California San Francisco - Children's Renal Center
1341
mi
from
San Francisco, CA
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
University of California San Francisco - Children's Renal Center
1341
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Children's Research Institute - The Children's Mercy Hospital
198
mi
from
Kansas City, MO
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Children's Research Institute - The Children's Mercy Hospital
198
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Brookview Hills Research Associates, LLC
976
mi
from
Winston-Salem, NC
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Brookview Hills Research Associates, LLC
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
1383
mi
from
Portland, OR
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
1383
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh School of Medicine - Division of Pediatric Nephrology
974
mi
from
Pittsburgh, PA
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh School of Medicine - Division of Pediatric Nephrology
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
The Warren Alpert Medical School of Brown University
1424
mi
from
Providence, RI
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
The Warren Alpert Medical School of Brown University
1424
mi
from
Providence, RI
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research, Inc.
781
mi
from
West Jordan, UT
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research, Inc.
781
mi
from
West Jordan, UT
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Hackensack Meridian School of Medicine
1285
mi
from
Hackensack, NJ
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Hackensack Meridian School of Medicine
1285
mi
from
Hackensack, NJ
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Akron Children's Hospital
898
mi
from
Akron, OH
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Akron Children's Hospital
898
mi
from
Akron, OH
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Akron Nephrology Associates
897
mi
from
Akron, OH
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Akron Nephrology Associates
897
mi
from
Akron, OH
Click here to add this to my saved trials
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated:  12/31/1969
Royal Brisbane and Women's Hospital
8347
mi
from
Herston,
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Status: Enrolling
Updated: 12/31/1969
Royal Brisbane and Women's Hospital
8347
mi
from
Herston,
Click here to add this to my saved trials
Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy
A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy
Status: Enrolling
Updated:  12/31/1969
Idaho Urologic Institute, P.A.
1050
mi
from
Meridian, ID
Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy
A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy
Status: Enrolling
Updated: 12/31/1969
Idaho Urologic Institute, P.A.
1050
mi
from
Meridian, ID
Click here to add this to my saved trials
Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy
A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy
Status: Enrolling
Updated:  12/31/1969
Columbus Urology Research, LLC
810
mi
from
Columbus, OH
Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy
A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy
Status: Enrolling
Updated: 12/31/1969
Columbus Urology Research, LLC
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy
A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy
Status: Enrolling
Updated:  12/31/1969
Urology Clinics of North Texas
342
mi
from
Dallas, TX
Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy
A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy
Status: Enrolling
Updated: 12/31/1969
Urology Clinics of North Texas
342
mi
from
Dallas, TX
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1175
mi
from
Beverly Hills, CA
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1175
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1179
mi
from
Los Angeles, CA
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1179
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1198
mi
from
Thousand Oaks, CA
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1198
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
400
mi
from
Denver, CO
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
400
mi
from
Denver, CO
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1100
mi
from
Clearwater, FL
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1100
mi
from
Clearwater, FL
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1130
mi
from
DeBary, FL
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1130
mi
from
DeBary, FL
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1205
mi
from
Fort Myers, FL
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1205
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1321
mi
from
Miami, FL
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1321
mi
from
Miami, FL
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1141
mi
from
Orlando, FL
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1141
mi
from
Orlando, FL
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1141
mi
from
Winter Park, FL
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1141
mi
from
Winter Park, FL
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
811
mi
from
Columbus, GA
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
811
mi
from
Columbus, GA
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
827
mi
from
Grand Blanc, MI
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
827
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
960
mi
from
Las Vegas, NV
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
960
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1301
mi
from
Great Neck, NY
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1301
mi
from
Great Neck, NY
Click here to add this to my saved trials
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
AURORA Investigative Center
1225
mi
from
New York, NY
Aurinia Renal Response in Active Lupus With Voclosporin
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
AURORA Investigative Center
1225
mi
from
New York, NY
Click here to add this to my saved trials